2027 Summer Intern - Business Strategy & Marketing Excellence

The role

This intern will support the North America Strategy team with business planning, strategic initiatives, marketing excellence, and launch excellence. You will collaborate with various functions to execute strategic business initiatives and lead a meaningful internship project.

What you will do

• Participate in strategy team meetings and contribute ideas for process improvements and project execution.
• Support BrandForward and other brand planning and lifecycle management initiatives.
• Assist stakeholders in executing strategic business initiatives.
• Research industry trends, policy developments, and business insights.
• Participate in learning and development opportunities.
• Lead a meaningful internship project and present findings to key stakeholders.

Required qualifications

• Rising sophomore, junior, or senior pursuing a degree in Business Administration, Finance, Life Sciences, Marketing, Healthcare Management, or a related field.
• Strong academic performance with coursework in business, marketing, operations, strategy, project management, or related disciplines.
• Proficiency in Microsoft Office, including Excel and PowerPoint.
• Strong analytical thinking, problem-solving, and organizational skills.
• Excellent written and verbal communication skills.
• Ability to manage multiple priorities, work independently, and collaborate effectively across teams.
• Interest in the pharmaceutical, biotechnology, or healthcare industry.
• Minimum GPA of 3.0.
• Must live within a commutable distance of Princeton, NJ.
• Authorized to work in the United States on a permanent and ongoing basis without sponsorship.

Nice to have

• Prior internship, leadership, or project experience

Benefits

• Mentorship from industry professionals

Before you apply

• Authorized to work in the United States on a permanent and ongoing basis without sponsorship.

About the company

Kyowa Kirin is a global specialty pharmaceutical company dedicated to discovering and advancing treatments for diseases in which unmet need is greatest.